Amneal has received the Food and Drug Administration’s permission for Propofol Injectable Emulsion, 200 mg/20 ml (10 mg/ml), 500 mg/50 ml (10 mg/ml) and 1,000 mg/100 mL (10 mg/ml), Single-Dose Vials.
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (“ANDA”) approval from ...